Progyny, Inc. (NASDAQ:PGNY) Given Average Rating of “Hold” by Analysts

Shares of Progyny, Inc. (NASDAQ:PGNY) have earned a consensus rating of “Hold” from the thirteen analysts that are covering the firm, Marketbeat reports. Nine investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $25.83.

Several analysts have recently weighed in on PGNY shares. Canaccord Genuity Group cut their price objective on Progyny from $18.00 to $17.00 and set a “hold” rating for the company in a report on Wednesday, November 13th. Truist Financial restated a “hold” rating and set a $19.00 target price (down from $26.00) on shares of Progyny in a report on Wednesday, November 13th. Bank of America increased their price objective on Progyny from $21.00 to $25.00 and gave the company a “buy” rating in a research report on Tuesday, February 11th. Barclays reduced their target price on Progyny from $30.00 to $17.00 and set an “overweight” rating for the company in a report on Thursday, November 14th. Finally, JPMorgan Chase & Co. lifted their price target on Progyny from $17.00 to $23.00 and gave the stock a “neutral” rating in a research note on Tuesday, January 28th.

Insider Activity

In other news, CEO Peter Anevski purchased 209,500 shares of the stock in a transaction that occurred on Monday, December 23rd. The shares were purchased at an average cost of $14.48 per share, for a total transaction of $3,033,560.00. Following the completion of the purchase, the chief executive officer now directly owns 441,463 shares of the company’s stock, valued at approximately $6,392,384.24. The trade was a 90.32 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Chairman David J. Schlanger acquired 150,000 shares of Progyny stock in a transaction on Thursday, December 26th. The stock was purchased at an average price of $14.68 per share, with a total value of $2,202,000.00. Following the transaction, the chairman now directly owns 228,269 shares in the company, valued at approximately $3,350,988.92. This trade represents a 191.65 % increase in their position. The disclosure for this purchase can be found here. 12.30% of the stock is owned by company insiders.

Institutional Investors Weigh In On Progyny

A number of institutional investors have recently added to or reduced their stakes in PGNY. International Assets Investment Management LLC grew its holdings in shares of Progyny by 1,576.0% in the 3rd quarter. International Assets Investment Management LLC now owns 2,565,118 shares of the company’s stock worth $42,991,000 after purchasing an additional 2,412,068 shares during the last quarter. Louisiana State Employees Retirement System raised its position in Progyny by 62.4% in the 3rd quarter. Louisiana State Employees Retirement System now owns 38,000 shares of the company’s stock valued at $637,000 after purchasing an additional 14,600 shares during the last quarter. State of Alaska Department of Revenue increased its stake in shares of Progyny by 397.7% in the third quarter. State of Alaska Department of Revenue now owns 44,819 shares of the company’s stock valued at $751,000 after buying an additional 35,813 shares in the last quarter. F M Investments LLC increased its position in Progyny by 58.7% in the 3rd quarter. F M Investments LLC now owns 18,078 shares of the company’s stock valued at $303,000 after acquiring an additional 6,684 shares in the last quarter. Finally, AlphaCentric Advisors LLC bought a new position in shares of Progyny in the third quarter worth about $126,000. 94.93% of the stock is owned by institutional investors and hedge funds.

Progyny Trading Down 0.5 %

Shares of NASDAQ:PGNY opened at $22.88 on Friday. Progyny has a twelve month low of $13.39 and a twelve month high of $38.98. The firm has a market cap of $1.95 billion, a P/E ratio of 39.45, a P/E/G ratio of 2.39 and a beta of 1.34. The company has a 50 day moving average of $20.52 and a 200-day moving average of $18.68.

Progyny Company Profile

Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.